Scientists in Miami are developing a “concussion pill” using cannabis that has so far shown great potential for the treatment of traumatic brain injuries.
A combination of the hemp-derived cannabinoid, cannabidiol (CBD), and an NMDA amino acid anesthetic has been shown to improve cognitive function in a pre-clinical study of rodents with traumatic brain injuries compared with the individual ingredients.
(CW) — Over the last several years, CBD (cannabidiol) has increasingly been shown to aid in the treatment of seizures, particularly in children. The evidence is so strong that the FDA, an organization notoriously opposed to cannabis, approved the first CBD-based medication for one particular seizure disorder at the end of June. Multiple studies have shown CBD is effective in treating these […]
UPDATE: The Associated Press changed its original story several minutes after our report was published, now saying the two deaths cannot be confirmed to have been caused by synthetic cannabis oil and adding that the figure 33 hospitalizations in Utah is closer to 40 but addresses the public, not military. (ANTIMEDIA) — Despite sustained efforts from military veterans to […]
(ANTIMEDIA) — According to a recent survey conducted by cannabis market research firm the Brightfield Group and HelloMD, an online medical cannabis community, nearly half of CBD (cannabidiol) users give up prescription drugs and over the counter medications in favor of the non-psychoactive substance.
In the largest survey to date on cannabidiol (CBD) usage, researchers found that nearly half of people using the products were able to quit using pharmaceutical drugs – something the pharmaceutical industry has long feared would happen.
The Brightfield Group and HelloMD – an online community that brings together doctors and cannabis patients – surveyed 2,400 people from HelloMD’s community of 150,000 members about their usage of CBD products and their effectiveness. [1]
Bethany Gomez, Director of Research for Brightfield Group, said:
A woman from Tucson, Arizona, says cannabidiol oil (CBD oil) treated her 12-year-old daughter of life-threatening seizures. The young girl suffers from a rare brain disorder and slipped into a coma after she vomited and had a seizure following a gymnastics competition. [1]
Annalise Lujan’s parents rejoiced after only 3 CBD oil treatments brought their daughter out of her coma and halted her crippling seizures.
Her mom, Maryann, said the speed at which their daughter’s illness forever changed her life was stunning.
Marijuana has been associated with reducing seizures in people with epilepsy for years, but only now is the topic getting more of the scientific scrutiny it deserves. In a recent study, cannabidiol (CBD) reduced the number of seizures by half in a substantial number of children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy.
GW Pharmaceuticals, a developer of cannabidiol, sponsored the study.
A young boy is shown taking CBD oil, a derivative of marijuana. (Photo: Jason David/Facebook)
(ANALYSIS) – After the DEA moved to further constrain, Americans’ access to medically miraculous CBD oil by classifying it alongside heroin and cocaine, Britain chose compassion and common sense — and just classified Cannabidiol (CBD) as a medicine.
On September 26, a marijuana-based childhood epilepsy drug took a step closer to winning approval when its maker announced promising phase 3 clinical trial results. [1]
Justin Gover, CEO of the British biotech company GW Pharmaceuticals, said that the children participating in the trial had previously tried 10 other anti-epileptic drugs. Despite using the medication, the young participants still experienced 3 seizures a day, approximately 90 a month. Said Gover:
Insys Therapeutics, a pharmaceutical company that sells fentanyl, an opioid painkiller 100 times stronger than morphine and 50 times stronger than heroin, is fighting pot legalization in Arizona with the most powerful weapon in business and politics: money. [1]
